Insider · CIK 0001566618

Guse Kyle

Reports to the SEC for 2 companies · HOUSTON, TX

sec.gov

Transactions

Companies

Filings

CIK

0001566618

Forms 4 and 5

Insider transactions

25 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-01	CNSYCERENOME, INC.M Exercise/Conversion	Director	MExercise/Conversion	+921 sh	—	—	1,843
2026-10-01	CNSYCERENOME, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−921 sh	—	—	1,843
2026-07-01	CNSYCERENOME, INC.M Exercise/Conversion	Director	MExercise/Conversion	+922 sh	—	—	922
2026-07-01	CNSYCERENOME, INC. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−922 sh	—	—	2,764
2026-05-14	CNSYCERENOME, INC. · Restricted Stock UnitsA Award	Director	AAward	+3,686 sh	—	—	3,686
2026-05-14	CNSYCERENOME, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+3,686 sh	—	—	3,686
2025-08-13	CNSYCERENOME, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+298K sh	—	—	297,794
2025-08-13	CNSYCERENOME, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2023-03-02	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	CFO, Gen Counsel and Secretary	AAward	+558K sh	—	—	557,900
2022-02-24	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	CFO, Gen Counsel and Secretary	AAward	+747K sh	—	—	746,667
2021-05-14	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	CFO, Gen Counsel and Secretary	AAward	+850K sh	—	—	850,000
2020-04-09	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	CFO, Gen Counsel and Secretary	AAward	+195K sh	—	—	195,000
2020-04-09	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	CFO, Gen Counsel and Secretary	AAward	+395K sh	—	—	395,000
2019-01-13	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	CFO, Gen Counsel and Secretary	DDisposition to Issuer	−700K sh	—	—	0
2019-01-13	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	CFO, Gen Counsel and Secretary	AAward	+800K sh	—	—	800,000
2018-06-27	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	CFO, Gen Counsel and Secretary	AAward	+700K sh	—	—	700,000
2018-05-30	ATOSATOSSA THERAPEUTICS, INC. · Series B Convertible Preferred StockP Purchase	CFO, Gen Counsel and Secretary	PPurchase	+8 sh	$1000.00	+$8,000	8
2018-05-30	ATOSATOSSA THERAPEUTICS, INC. · WarrantsP Purchase	CFO, Gen Counsel and Secretary	PPurchase	+2,272 sh	$1000.00	+$2.27M	2,272
2017-11-15	ATOSATOSSA THERAPEUTICS, INC.P Purchase	CFO, Gen Counsel and Secretary	PPurchase	+8,600 sh	$0.34	+$2,898.2	8,600
2017-11-15	ATOSATOSSA THERAPEUTICS, INC.P Purchase	CFO, Gen Counsel and Secretary	PPurchase	+1,400 sh	$0.34	+$471.1	10,000
2017-05-24	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	CFO, Gen Counsel and Secretary	AAward	+495K sh	—	—	640,667
2016-05-18	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	CFO, Gen Counsel and Secretary	AAward	+1.09M sh	—	—	1,090,000
2015-03-16	ATOSATOSSA THERAPEUTICS, INC. · Stock OptionsA Award	CFO, Gen Counsel and Secretary	AAward	+190K sh	—	—	190,000
2014-01-08	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	CFO, Gen Counsel and Secretary	AAward	+140K sh	—	—	140,000
2013-06-04	ATOSATOSSA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	CFO, Gen Counsel and Secretary	AAward	+60K sh	—	—	60,000

Recent filings

Accepted (ET)
Oct 14
Guse Kyle0001193125-26-409855
SEC(opens sec.gov)
Jul 14
Guse Kyle0001193125-26-292644
SEC(opens sec.gov)
May 184
Guse Kyle0001193125-26-228929
SEC(opens sec.gov)
Aug 154
Guse Kyle0000950170-25-109414
SEC(opens sec.gov)
Mar 64
Guse Kyle0001437749-23-005531
SEC(opens sec.gov)
Feb 284
Guse Kyle0001437749-22-004668
SEC(opens sec.gov)
May 184
Guse Kyle0001437749-21-012675
SEC(opens sec.gov)
Apr 134
Guse Kyle0001437749-20-007630
SEC(opens sec.gov)
Jan 154
Guse Kyle0001615774-19-000644
SEC(opens sec.gov)
Jun 294
Guse Kyle0001615774-18-006001
SEC(opens sec.gov)
May 314
Guse Kyle0001615774-18-004655
SEC(opens sec.gov)
Nov 164
Guse Kyle0001615774-17-006777
SEC(opens sec.gov)

Companies

Address

C/O PLUS THERAPEUTICS INC. 6420 LEVIT GREEN BOULEVARD, SUITE 310

HOUSTON, TX, 77021